Cargando…
Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2
Autores principales: | Davidson, Natalie, Evans, Jenny, Robson, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221908/ http://dx.doi.org/10.1016/j.pathol.2021.06.104 |
Ejemplares similares
-
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
por: Seow, Han Cong, et al.
Publicado: (2023) -
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
por: Pang, Natalie Yan-Lin, et al.
Publicado: (2021) -
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
por: Kemp, SA, et al.
Publicado: (2020) -
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021) -
SARS-CoV-2 neutralising antibodies in dogs and cats in the United Kingdom
por: Smith, Shirley L., et al.
Publicado: (2021)